TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Applications for Parkinson’s Disease Centers of Excellence Encouraged

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS) invites applications for the Morris K. Udall Parkinson’s Disease Centers of Excellence Program.*

Morris K. Udall Parkinson’s Disease Research Centers contribute to the basic understanding of the pathology of Parkinson’s disease (PD).  Each center contains basic, translational, or clinical research, or proportions of each that are appropriate for the research objectives.  Research objectives emphasize basic, translational, or clinical studies of PD, parkinsonisms, and related disorders.  Emphasis is placed on multidisciplinary and collaborative studies that are carried out best in a center setting.

Areas of interest include, but are not limited to:  development of therapeutics for treating PD, including pharmacological, gene therapy, cell replacement, or surgical approaches; studies to address the non-motor aspects of PD, including dementia, depression, psychosis, cognitive impairment, etc., including development of animal models which recapitulate non-motor aspects of PD; the natural history of PD and related disorders including prospective clinical assessment, neuropathological analysis, and banking of brain tissue from individuals with PD who agree to participate in an autopsy program; genetic, molecular, and cell biological studies of the structure, function, composition, role, and possible interrelationship of cellular proteins and inclusion bodies implicated in the pathogenesis of PD and related disorders; development of biomarkers for PD onset, progression, or response to therapeutics; cellular and molecular mechanisms of cell injury and death in PD and related neurodegenerative disorders; development of animal models and their use for investigation of pathophysiology and efficacy of therapeutic intervention; and development and function of the neural circuitry involved in PD and related disorders

For more information, potential applicants should contact Dr. Diane Murphy, Program Director, Neurodegeneration Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2222, Bethesda, MD  20892; telephone:  301-496-5680; fax:  301-480-1080; e-mail:

*For   a more detailed description of this announcement, please visit: